Entity Detail — Knowledge Graph Node
This page aggregates everything SciDEX knows about KYNURENINE PATHWAY: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.
Knowledge base pages for this entity
| Target | Relation | Type | Str |
|---|---|---|---|
| Redox Balance | regulates | process | 0.90 |
| aging | associated_with | phenotype | 0.90 |
| ADHD | associated_with | disease | 0.85 |
| Neurodegeneration | associated_with | disease | 0.85 |
| ADHD | biomarker_for | disease | 0.80 |
| ALZHEIMER'S DISEASE | contributes_to | disease | 0.80 |
| Alzheimer's Disease | contributes_to | disease | 0.75 |
| Alzheimer's disease | associated_with | disease | 0.70 |
| NEURODEGENERATION | interacts_with | disease | 0.65 |
| NEURODEGENERATION | treats | disease | 0.65 |
| MULTIPLE SCLEROSIS | causes | disease | 0.65 |
| EXCITOTOXICITY | activates | phenotype | 0.65 |
| MICROGLIA | protects_against | cell_type | 0.65 |
| SEROTONIN | activates | phenotype | 0.65 |
| INFLAMMATION | implicated_in | phenotype | 0.55 |
| KYNURENINE | associated_with | phenotype | 0.45 |
| INFLAMMATION | associated_with | phenotype | 0.45 |
| CYTOKINES | associated_with | phenotype | 0.45 |
| NEUROINFLAMMATION | associated_with | phenotype | 0.45 |
| ASTROCYTES | associated_with | cell_type | 0.45 |
| DEMENTIA | associated_with | disease | 0.45 |
| NEURONS | associated_with | cell_type | 0.45 |
| EXCITOTOXICITY | associated_with | phenotype | 0.45 |
| MICROGLIA | associated_with | cell_type | 0.45 |
| SEROTONIN | associated_with | phenotype | 0.45 |
| HIPPOCAMPUS | associated_with | brain_region | 0.45 |
| PYROPTOSIS | associated_with | phenotype | 0.45 |
| NEUROGENESIS | associated_with | phenotype | 0.45 |
| OXIDATIVE STRESS | associated_with | phenotype | 0.45 |
| DOPAMINE | associated_with | phenotype | 0.45 |
| MELATONIN | associated_with | drug | 0.45 |
| NICOTINAMIDE | associated_with | drug | 0.45 |
| TRYPTOPHAN METABOLISM | implicated_in | process | 0.35 |
| OXIDATIVE STRESS | regulates | process | 0.35 |
| Source | Relation | Type | Str |
|---|---|---|---|
| IDO | activates | enzyme | 0.90 |
| TDO | activates | enzyme | 0.90 |
| Indoleamine 2,3-Dioxygenase | regulates | enzyme | 0.85 |
| INFLAMMATION | activates | phenotype | 0.65 |
| CYTOKINES | activates | phenotype | 0.65 |
| NEURODEGENERATION | inhibits | disease | 0.65 |
| MELATONIN | activates | drug | 0.65 |
| OXIDATIVE STRESS | regulates | process | 0.50 |
| MULTIPLE SCLEROSIS | associated_with | disease | 0.45 |
| HUNTINGTON'S DISEASE | associated_with | disease | 0.45 |
| PARKINSON'S DISEASE | associated_with | disease | 0.45 |
Hypotheses where this entity is a therapeutic target
| Hypothesis | Score | Disease | Analysis |
|---|---|---|---|
| No targeting hypotheses | |||
Scientific analyses that reference this entity
No analyses mention this entity
Experimental studies targeting or related to this entity
| Experiment | Type | Disease | Score | Feasibility | Model | Status | Est. Cost |
|---|---|---|---|---|---|---|---|
| No experiments found | |||||||
Scientific publications cited in analyses involving this entity
| Title & PMID | Authors | Journal | Year | Citations |
|---|---|---|---|---|
| No papers found | ||||